Brief: Bioceltix Veterinary Biological Drug Project InnoBioVet Recommended For 15.1 Million Zloty Subsidy
30/04/2026 05:19
April 30 (Reuters) - Bioceltix BCXP.WA: SAID ON WEDNESDAY THAT IT HAD RECEIVED A POSITIVE EVALUATION FROM POLAND'S NCBR (NATIONAL CENTRE FOR RESEARCH AND DEVELOPMENT) FOR INNOBIOVET PROJECT PROJECT AIMS TO DEVELOP BIOLOGICAL VETERINARY DRUG FOR TREATING ATOPIC DERMATITIS IN DOGS RECOMMENDED SUBSIDY AMOUNT TOTALS 15.1 MILLION ZLOTYS TOTAL PROJECT VALUE ESTIMATED AT 19.5 MILLION ZLOTYS Source text: nEM2sBtF9a Further company coverage: BCXP.WA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Bioceltix SA
See all newsBrief: Bioceltix Signs 2 Mln Zlotys Net Deal With Intero For Construction Works
Brief: Bioceltix Receives Permit For Biological Veterinary Drugs Facility
Brief: Bioceltix Veterinary Biological Drug Project InnoBioVet Recommended For 15.1 Million Zloty Subsidy
Brief: Bioceltix Signs Advisory Agreement For FDA Regulatory Support
Brief: Bioceltix Gets GMP Certificate For Wroclaw Veterinary Medicine Facility